Norma J. Storer

发表

Changes in Inflammation, Oxidative Stress, Mitochondrial DNA Content after Rosiglitazone in HIV Lipoatrophy.

G. McComsey, G. Milne, U. Walker, 2012, Journal of AIDS & clinical research.

Long-Term Changes in Carotid Intima-Media Thickness among HIV-Infected Children and Young Adults

G. McComsey, M. O'riordan, A. Eckard, 2014, Antiviral therapy.

Carotid intima media thickness, inflammatory markers, and endothelial activation markers in HIV Patients with lipoatrophy increased at 48 weeks regardless of use of rosiglitazone or placebo.

G. McComsey, M. O'riordan, N. Rizk, 2011, AIDS research and human retroviruses.

Heightened inflammation is linked to carotid intima-media thickness and endothelial activation in HIV-infected children.

G. McComsey, M. O'riordan, V. Dogra, 2010, Atherosclerosis.

Longitudinal Changes in Carotid Intima-Media Thickness and Cardiovascular Risk Factors in Human Immunodeficiency Virus-Infected Children and Young Adults Compared With Healthy Controls

G. McComsey, V. Dogra, N. Storer, 2010, The Pediatric infectious disease journal.

Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy.

G. McComsey, M. O'riordan, N. Rizk, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Increased carotid intima media thickness and cardiac biomarkers in HIV infected children

S. Hazen, D. Nakamoto, M. Brennan, 2007, AIDS.

Vitamin D Supplementation and Endothelial Function in Vitamin D Deficient HIV-Infected Patients: A Randomized Placebo-Controlled Trial

C. Longenecker, T. Brown, G. McComsey, 2012, Antiviral Therapy.

Omega-3 fatty acids do not improve endothelial function in virologically suppressed HIV-infected men: a randomized placebo-controlled trial.

G. McComsey, T. Carman, N. Storer, 2012, AIDS research and human retroviruses.

Endothelial Activation Markers Are Linked to HIV Status and Are Independent of Antiretroviral Therapy and Lipoatrophy

G. McComsey, M. O'riordan, N. Rizk, 2008, Journal of acquired immune deficiency syndromes.

Perivascular fat, inflammation, and cardiovascular risk in HIV-infected patients on antiretroviral therapy.

M. Lederman, C. Longenecker, G. McComsey, 2013, International journal of cardiology.

Mitochondrial Function, Inflammation, Fat and Bone in HIV Lipoatrophy: Randomized Study of Uridine Supplementation or Switch to Tenofovir

M. Gerschenson, G. McComsey, M. O'riordan, 2012, Antiviral therapy.

HIV vasculopathy: role of mononuclear cell-associated Krüppel-like factors 2 and 4

C. Longenecker, G. McComsey, S. Debanne, 2015, AIDS.

Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy.

G. McComsey, M. O'riordan, V. Dogra, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection

M. Lederman, R. Gilkeson, C. Longenecker, 2014, AIDS.

Lipoprotein‐associated phospholipase A2 and cardiovascular disease risk in HIV infection

C. Longenecker, G. McComsey, S. Debanne, 2014, HIV medicine.

The Relationship Between Vitamin D Status and HIV-related Complications in HIV-infected Children and Young Adults

G. McComsey, M. O'riordan, V. Tangpricha, 2013, The Pediatric infectious disease journal.

Vitamin D is Linked to Carotid Intima-Media Thickness and Immune Reconstitution in HIV-Positive Individuals

M. Kumari, S. Judd, G. McComsey, 2011, Antiviral therapy.

Heightened inflammation is linked to carotid intima-media thickness and endothelial activation in HIV-infected children.

G. McComsey, M. O'riordan, V. Dogra, 2010, Atherosclerosis.

Effects of in utero antiretroviral exposure on mitochondrial DNA levels, mitochondrial function and oxidative stress

A. Avery, G. McComsey, D. Lebrecht, 2012, HIV medicine.

Bone Effects of Rosiglitazone in HIV-Infected Patients With Lipoatrophy

T. Brown, G. McComsey, N. Fedarko, 2012, HIV clinical trials.

Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy.

M. Lederman, G. McComsey, S. Debanne, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Markers of inflammation and CD8 T‐cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV‐infected individuals

M. Lederman, C. Longenecker, G. McComsey, 2013, HIV medicine.

Is bone loss linked to chronic inflammation in antiretroviral-naive HIV-infected adults? A 48-week matched cohort study

G. McComsey, V. Tangpricha, N. Storer, 2014, AIDS.

Bone Turnover, Osteoprotegerin/Rankl and Inflammation with Antiretroviral Initiation: Tenofovir versus Non-Tenofovir Regimens

T. Brown, G. McComsey, N. Storer, 2011, Antiviral therapy.

Bone turnover , OPG / RANKL , and inflammation with antiretroviral initiation : comparison of tenofovir-vs . non-tenofovir regimens

T. Brown, G. McComsey, N. Storer, 2022 .

Elevated D-Dimer is Independently Associated with Endothelial Dysfunction: A Cross-Sectional Study in HIV-Infected Adults on Antiretroviral Therapy

C. Longenecker, G. McComsey, G. Milne, 2012, Antiviral therapy.

Mitochondrial RNA and DNA alterations in HIV lipoatrophy are linked to antiretroviral therapy and not to HIV infection

M. Gerschenson, G. McComsey, M. O'riordan, 2008, Antiviral therapy.

Rate and Predictors of Carotid Artery Intima Media Thickness Progression in Antiretroviral-Naive HIV-Infected and Uninfected Adults: A 48-Week Matched Prospective Cohort Study

C. Longenecker, G. McComsey, T. Carman, 2013, Antiviral therapy.